Fassero Daniel J MD - 17870 Selinsgrove, PA

Business Name: Fassero Daniel J MD
Categorized In: Doctors
Address: 15 Susquehanna Avenue, Selinsgrove, PA 17870
Phone Number: (570) 743-7999
Contact Person: Daniel Fassero
Website Address: eyecenterofpa.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: V Passi - Selinsgrove, PA 17870
Pa Institute of Neurology - Selinsgrove, PA 17870
Pagana II Charles M MD - Selinsgrove, PA 17870
Callaghan Jr James S MD - Selinsgrove, PA 17870
Kumar Ashok MD - Selinsgrove, PA 17870
Del Castillo Juan MD - Selinsgrove, PA 17870
Askari Hasan MD - Selinsgrove, PA 17870
Patel Mayur MD - Selinsgrove, PA 17870
Randolph Victor MD - Selinsgrove, PA 17870
Chlebowski James E MD - Selinsgrove, PA 17870
Whipple Bonnie L PhD - Selinsgrove, PA 17870
Edinger Andrew M MD - Selinsgrove, PA 17870
Peters Lidia MD - Selinsgrove, PA 17870
Pagana Charles C MD - Selinsgrove, PA 17870
Nelson E Bailey Dr - Selinsgrove, PA 17870
Yavorek Henry G MD - Selinsgrove, PA 17870
Bhangdia Darshan K MD - Selinsgrove, PA 17870
Susquehanna Valley Cancer Center - Selinsgrove, PA 17870
Anthony Catalano Dr - Selinsgrove, PA 17870
Family Practice Center - Selinsgrove, PA 17870

Fassero Daniel J MD provides professional Doctors from its single location at the coordinates 40.81336,-76.85896.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 15 Susquehanna Avenue, Selinsgrove, Pennsylvania 17870 or contacted through representative Daniel Fassero at (570) 743-7999.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Fassero Daniel J MD through its company website at eyecenterofpa.com. Engage with this business on its social media platforms through on Twitter and on Facebook.